Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer
Clinical trial NCT00106002 · COMPLETED
Trial details
- NCT number
- NCT00106002
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2007-12-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.